October 2020

UROLOGY

INVESTIGATING AND REDUCING GENDER DISPARITIES IN BLADDER CANCER

Featuring: Joshua J. Meeks, MD, PhD

Episode Summary

Metastatic bladder cancer is one of the most aggressive, treatment refractory solid tumors and female gender is associated with a 20 percent worse survival rate than is the male gender. Joshua Meeks, MD, PhD, assistant professor in the Divisions of Urology and Biochemistry and Molecular Genetics at Northwestern Medicine, is investigating the gender disparities in bladder cancer by dissecting the tumor and immune mechanisms of resistance to chemotherapy and immunotherapy. This research may translate into novel pathways and potential therapeutic targets to improve outcomes and reduce gender disparities in bladder cancer. In this video, Dr. Meeks shares details about his work.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like